Market revenue in 2023 | USD 8.0 million |
Market revenue in 2030 | USD 14.1 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 53.75% in 2023. Horizon Databook has segmented the South Africa mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
In South Africa, organizations such as the Centre for Proteomic and Genomic Research (CPGR) enable cell culture-based screening for faster drug development, creating a demand for mycoplasma testing products. Key players operating in the country include Merck KGaA, Sartorius, Thermo Fisher Scientific, and others. Moreover, growing interest by global players in setting up manufacturing units for vaccines in the country is expected to contribute to market growth.
For instance, in September 2021, Numolux Group and Sinovac Biotech entered into a discussion to develop a new manufacturing facility for vaccines in South Africa for various diseases. This was anticipated to generate market demand for mycoplasma testing products.
Furthermore, rising number of workshops & symposiums on cell culture technologies in the country are anticipated to spread awareness about advanced cell biology technologies in South Africa, which is likely to fuel the demand for mycoplasma testing for QC purposes.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account